Elligo Health Research

Enables community and specialty practices to run trials, using access to health records to identify eligible patients inside an existing physician relationship rather than recruiting strangers.

Per-study site network agreements, often per-patient-enrolled components.

Whatever the structure, convert it to cost per randomized patient before you compare proposals. Cost per referral is the number vendors prefer to quote and the number that tells you least.

• Patients come with a treating physician who already knows them
• Record-based identification beats advertising for eligibility precision
• Reaches patients who never search for trials

• Depends on which practices and specialties are live in your therapeutic area
• Newly activated practices are inexperienced sites; expect training overhead

Worth it when: Indications managed in community practice — cardiometabolic, primary care, common specialties.

Not worth it when: Highly specialized academic-centre indications.

• Deep 6 AIMines clinical records, including unstructured notes, to find eligible patients.
• Science 37Decentralized trial operating system with telemedicine investigators and nurses.
• AcurianLarge-scale outreach using consumer data, part of a major CRO.

• Elligo Health Research vs Acurian — Community practice records versus consumer-data outreach.

Ask for the referral-to-randomization ratio on three studies resembling yours, in the same indication and the same countries. If a vendor will not give it, that is the answer. If your enrollment forecast itself is the shaky part, our sister publication Rock Enroll covers forecasting and rescue in depth.